TY - JOUR
T1 - Roles for biological membranes in regulating human immunodeficiency virus replication and progress in the development of HIV therapeutics that target lipid metabolism
AU - Haughey, Norman J.
AU - Tovar-Y-Romo, Luis B.
AU - Bandaru, Veera Venkata Ratnam
N1 - Funding Information:
Acknowledgment The authors have no conflicts of interest to report. This work was supported by NIH grants MH077542, AA017408, AG034849,
PY - 2011/6
Y1 - 2011/6
N2 - Infection by the human immunodeficiency virus (HIV) involves a number of important interactions with lipid components in host membranes that regulate binding, fusion, internalization, and viral assembly. Available data suggests that HIV actively modifies the sphingolipid content of cellular membranes to create focal environments that are favorable for infection. In this review, we summarize the roles that membrane lipids play in HIV infection and discuss the current status of therapeutics that attempt to modify biological membranes to inhibit HIV.
AB - Infection by the human immunodeficiency virus (HIV) involves a number of important interactions with lipid components in host membranes that regulate binding, fusion, internalization, and viral assembly. Available data suggests that HIV actively modifies the sphingolipid content of cellular membranes to create focal environments that are favorable for infection. In this review, we summarize the roles that membrane lipids play in HIV infection and discuss the current status of therapeutics that attempt to modify biological membranes to inhibit HIV.
KW - HIV
KW - Lipid raft
KW - Sphingolipid
KW - Therapeutics
UR - http://www.scopus.com/inward/record.url?scp=79957442535&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79957442535&partnerID=8YFLogxK
U2 - 10.1007/s11481-011-9274-7
DO - 10.1007/s11481-011-9274-7
M3 - Review article
C2 - 21445582
AN - SCOPUS:79957442535
SN - 1557-1890
VL - 6
SP - 284
EP - 295
JO - Journal of Neuroimmune Pharmacology
JF - Journal of Neuroimmune Pharmacology
IS - 2
ER -